Tag: Africa

Explore all our news . .

Recent Posts

Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services. “This is an exciting time

Call for Entries Issued for The 21st Annual International Business Awards®

New Technology Solution Awards Categories for Artificial Intelligence Call for Entries Issued for The 21st Annual International Business Awards® FAIRFAX, Va., Feb. 22, 2024 (GLOBE NEWSWIRE) — The Stevie® Awards are now accepting nominations for The 21st Annual International Business Awards®, the world’s premier business awards competition, attracting nominations from

Lantronix Announces Percepxion™, Its New Cloud Software Platform for IoT Devices

Percepxion™ comes pre-configured in Lantronix’s gateways, routers, trackers and switches to accelerate IoT edge device deployments IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions, today announced Percepxion™, its new Cloud IoT Edge Solutions platform. Percepxion is pre-configured

Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 Mont-Saint-Guibert, Belgium – February 15, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to